CT:IQ is delighted to announce the addition of Contract Research Organisation (CRO) Fortrea to our Steering Committee.
Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. Fortrea partners with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services.
Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network.
We look forward to collaborating with Fortrea to drive meaningful change that will impact patients, researchers, and stakeholders across the clinical research sector in Australia.
